Allspring Global Investments Holdings LLC Lowers Stock Holdings in Maximus, Inc. $MMS

Allspring Global Investments Holdings LLC reduced its position in shares of Maximus, Inc. (NYSE:MMS) by 21.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 415,876 shares of the health services provider’s stock after selling 111,017 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Maximus were worth $35,961,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Arizona State Retirement System raised its holdings in shares of Maximus by 0.9% in the 3rd quarter. Arizona State Retirement System now owns 16,674 shares of the health services provider’s stock valued at $1,524,000 after acquiring an additional 156 shares in the last quarter. GAMMA Investing LLC increased its stake in Maximus by 13.9% in the third quarter. GAMMA Investing LLC now owns 1,337 shares of the health services provider’s stock valued at $122,000 after acquiring an additional 163 shares during the last quarter. Trust Point Inc. increased its stake in Maximus by 3.7% in the third quarter. Trust Point Inc. now owns 5,286 shares of the health services provider’s stock valued at $483,000 after acquiring an additional 191 shares during the last quarter. Richardson Financial Services Inc. raised its position in Maximus by 123.1% during the third quarter. Richardson Financial Services Inc. now owns 348 shares of the health services provider’s stock valued at $32,000 after purchasing an additional 192 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Maximus by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock valued at $2,351,000 after purchasing an additional 221 shares in the last quarter. Institutional investors own 97.21% of the company’s stock.

Wall Street Analysts Forecast Growth

MMS has been the topic of several research reports. Weiss Ratings downgraded shares of Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research note on Tuesday, February 24th. Zacks Research upgraded shares of Maximus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 30th. Finally, Wall Street Zen downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research note on Monday, February 23rd. One investment analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, Maximus presently has an average rating of “Buy”.

Insider Buying and Selling at Maximus

In other Maximus news, CEO Bruce Caswell bought 3,175 shares of the stock in a transaction dated Tuesday, February 10th. The stock was purchased at an average cost of $78.45 per share, for a total transaction of $249,078.75. Following the completion of the acquisition, the chief executive officer owned 328,013 shares of the company’s stock, valued at approximately $25,732,619.85. This trade represents a 0.98% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Jan Madsen sold 742 shares of the business’s stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total value of $53,609.50. Following the completion of the sale, the director directly owned 20,795 shares in the company, valued at approximately $1,502,438.75. This represents a 3.45% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 1.80% of the company’s stock.

Maximus Stock Down 0.4%

Shares of NYSE:MMS opened at $62.32 on Friday. Maximus, Inc. has a 52-week low of $60.75 and a 52-week high of $100.00. The firm has a market capitalization of $3.40 billion, a P/E ratio of 9.49 and a beta of 0.63. The stock has a 50 day moving average price of $76.48 and a 200-day moving average price of $83.63. The company has a debt-to-equity ratio of 0.88, a quick ratio of 2.34 and a current ratio of 2.34.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share for the quarter, beating the consensus estimate of $1.84 by $0.01. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.37 billion. Maximus had a return on equity of 25.30% and a net margin of 6.92%.The firm’s revenue was down 4.1% on a year-over-year basis. During the same period in the previous year, the company posted $1.61 earnings per share. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. As a group, equities research analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 2nd. Stockholders of record on Friday, February 13th were issued a dividend of $0.33 per share. This is a boost from Maximus’s previous quarterly dividend of $0.30. The ex-dividend date was Friday, February 13th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.1%. Maximus’s dividend payout ratio (DPR) is presently 20.09%.

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.